---
figid: PMC6400835__fonc-09-00081-g0005
figlink: /pmc/articles/PMC6400835/figure/F5/
number: F5
caption: Effects of EBV latent and lytic proteins on inhibition of apoptosis. EBNA-1
  interacts with the HAUSP to destabilize and degrade p53. EBNA-2 antagonizes TGF-β-mediated
  growth arrest in LCLs. LMP-1 upregulates Bcl-2 and promotes the growth of BL through
  the activation of NF-kB signaling pathway. EBNA-3A upregulates Hsp70 chaperones
  to suppress the apoptosis in exposure to cytotoxic agents. EBNA-3C can suppress
  p53-dependent apoptosis through repressing the transcription of p53 and promoting
  its degradation. EBNA-3C also hinders the E2F1-mediated apoptosis induced by DNA
  damage response through inhibiting the DNA binding activity of E2F1 and promoting
  its proteolysis. EBNA-3C also interacts with Bcl-6 and releases the Bcl-2 to suppress
  apoptosis. EBNA-3A and -3C can co-operate to repress the expression of p16INK4a
  and Bim to promote cell proliferation. Zta can induce the expression of vascular
  endothelial growth factor (VEGF) to promote the growth of LCL.
pmcid: PMC6400835
papertitle: Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases.
reftext: Kwai Fung Hui, et al. Front Oncol. 2019;9:81.
pmc_ranked_result_index: '42512'
pathway_score: 0.9603694
filename: fonc-09-00081-g0005.jpg
figtitle: EBV latent and lytic proteins on inhibition of apoptosis
year: '2019'
organisms: Homo sapiens
ndex: 21bf9c8a-ded4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6400835__fonc-09-00081-g0005.html
  '@type': Dataset
  description: Effects of EBV latent and lytic proteins on inhibition of apoptosis.
    EBNA-1 interacts with the HAUSP to destabilize and degrade p53. EBNA-2 antagonizes
    TGF-β-mediated growth arrest in LCLs. LMP-1 upregulates Bcl-2 and promotes the
    growth of BL through the activation of NF-kB signaling pathway. EBNA-3A upregulates
    Hsp70 chaperones to suppress the apoptosis in exposure to cytotoxic agents. EBNA-3C
    can suppress p53-dependent apoptosis through repressing the transcription of p53
    and promoting its degradation. EBNA-3C also hinders the E2F1-mediated apoptosis
    induced by DNA damage response through inhibiting the DNA binding activity of
    E2F1 and promoting its proteolysis. EBNA-3C also interacts with Bcl-6 and releases
    the Bcl-2 to suppress apoptosis. EBNA-3A and -3C can co-operate to repress the
    expression of p16INK4a and Bim to promote cell proliferation. Zta can induce the
    expression of vascular endothelial growth factor (VEGF) to promote the growth
    of LCL.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TP53
  - TGFB1
  - REL
  - RELA
  - RELB
  - NFKB2
  - TGFB3
  - PGF
  - BCL2
  - TGFB2
  - MDM2
  - CDKN2A
  - BCL2L11
  - E2F1
  - NFKB1
  - VEGFA
  - BCL6
  - VEGFD
  - VEGFC
  - USP7
  - VEGFB
  - EBNA
  - EBNA-3C
  - Cancer
genes:
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: p16
  symbol: p16
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: Bim
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: E2F1
  symbol: E2F1
  source: hgnc_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: Bcl-6
  symbol: BCL6
  source: hgnc_symbol
  hgnc_symbol: BCL6
  entrez: '604'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: HAUSP
  symbol: HAUSP
  source: hgnc_prev_symbol
  hgnc_symbol: USP7
  entrez: '7874'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
chemicals:
- word: EBNA
  source: MESH
  identifier: C417029
- word: EBNA-3C
  source: MESH
  identifier: C417029
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6400835__F5
redirect_from: /figures/PMC6400835__F5
figtype: Figure
---
